Reference health

Predictors of Relapses or Recurrences in Patients with Giant Cell Arteritis: A Retrospective Study

https://doi.org/10.2139/ssrn.4093662
CiteStamped reference-health badge
25/25 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 25 checked references that resolve
resolves10.1016/S0140-6736(08)61077-6
Polymyalgia rheumatica and giant-cell arteritis
resolves10.1038/nrrheum.2012.97
Clinical features of polymyalgia rheumatica and giant cell arteritis
resolves10.2174/1573397115666190227194014
Giant Cell Arteritis (GCA): Pathogenesis, Clinical Aspects and Treatment Approaches
resolves10.1136/annrheumdis-2011-200865
Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography
resolves10.1136/annrheumdis-2012-202408
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis
resolves10.1093/rheumatology/keu329
Large-vessel giant cell arteritis: a cohort study
resolves10.1097/MD.0000000000003851
18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis
resolves10.1016/j.revmed.2015.12.015
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
resolves10.3899/jrheum.141347
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study
resolves10.1097/MD.0b013e31821c4fad
Relapses and Recurrences in Giant Cell Arteritis
resolves10.1097/MD.0000000000000033
Relapses in Patients With Giant Cell Arteritis
resolves10.1097/MD.0000000000003524
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy
resolves10.1093/rheumatology/kev348
Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study
resolves10.1002/art.11388
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
resolves10.3899/jrheum.181127
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis
resolves10.1016/j.ejim.2021.03.040
Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: A systematic review and meta-analysis
resolves10.1136/bcr-2020-234734
Giant cell arteritis manifested by chronic dry cough
resolves10.1007/s00296-012-2415-3
Dry cough is a frequent manifestation of giant cell arteritis
resolves10.1016/S0248-8663(01)00400-3
Symptômes inauguraux de la maladie de Horton sur une série de 260 patients
resolves10.1002/art1.10161
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant‐cell arteritis
resolves10.3109/14397595.2015.1081722
Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis
resolves10.1093/rheumatology/keaa080
Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis
resolves10.1016/j.jdiacomp.2020.107723
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
resolves10.3899/jrheum.120511
Giant Cell Arteritis with or without Aortitis at Diagnosis. A Retrospective Study of 22 Patients with Longterm Followup
resolves10.1136/annrheumdis-2019-215672
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
The 7 references without a DOI — listed, not checked
no DOI — not checkedref2
no DOI — not checkedlaboratory, radiological features, and outcome in 26 patients with aortic involvement amongst a case series of 63 patients with giant cell arteritis]
no DOI — not checkedTreatment with methotrexate and risk of relapses in patients with giant cell arteritis in clinical practice
no DOI — not checkedPulmonary Involvement in Primary Systemic Vasculitides
no DOI — not checkedRespiratory and otolaryngologic manifestations of giant cell arteritis
no DOI — not checkedRespiratory system involvement in systemic vasculitides
no DOI — not checkedVasculoprotective Effects of Vildagliptin
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4093662"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4093662/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4093662/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4093662)